about bpl

Bio Products Laboratory Ltd.

News

PRESS RELEASE: Creat Group Corporation agrees to acquire Bio Products Laboratory Ltd.

Elstree, 19 May, 2016 – Bio Products Laboratory Ltd. (“BPL”), a leading plasma biotherapeutics company, today announces that a group controlled by Creat Group Corporation (“Creat”), has signed a definitive agreement to acquire the company for a total cash consideration of £820 million. BPL, headquartered in ...

Date added: Thursday 19th May 2016
Latest updated: Wednesday 8th February 2017

Patient information leaflets